CD4 and myeloid sarcoma: Inhibition of p38 MAPK signaling via the T cell receptor in CD4+ T cells led to reduced production of IFN-γ and IL-17 and reduced severity of animal autoimmune disease models for MS and rheumatoid arthritis40.